Most safety information comes from preclinical studies and extrapolation from the known safety profiles of related compounds
4.1 Antifungal drugs targeting the cell wall Recent advances in antifungal therapy have introduced new agents targeting the fungal cell wall, notably Ibrexafungerp and Rezafungin, both of which have shown promising results in clinical trials against Candida albicans , Candida auris , and Aspergillus spp (Spec et al., 2019
Most of the clinical studies monitored the effect of commercially available CLA supplements, which usually contain a mixture of 9- and 10-CLAs at approximately 50:50 ratio, whereas some other researchers used naturally CLA-enriched dairy products for evaluating the biological activities
The release of insulin is a natural process that is advantageous for muscle development and recovery
Sirtuin (SIRT1SIRT7) activity assays, where NAD+ is the co-substrate and nicotinamide release is quantified
These are not reasons to dismiss the compounds research value